Tensha Therapeutics, Inc.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Tensha Therapeutics, Inc.
Scrip
• By Jessica Merrill
As the president of Novartis AG's Institute for Biomedical Research, James (Jay) Bradner oversees drug discovery and early development at the big pharma, committing resources to going after "high-ha
In Vivo
• By Maureen Riordan and Amanda Micklus
Financings During the first quarter of 2016, biopharma financing totaled $5.7 billion, a 56% decrease over the previous quarter's $13.1 billion. (Keep in mind, over half of the Q4 2015 total came from
In Vivo
• By Amanda Micklus
Strategic Transactions Exhibit 4 Six-Month Snapshot Of Public And Private Financing
In Vivo
• By Nancy Dvorin
Top Alliance: MannKind Licenses Technosphere to Receptor Stealthy start-up Receptor Life Sciences Inc. has licensed MannKind Corp. 's Technosphere dry powder delivery platform to develop inha